Wilson Auditory Brainstem Implant Program
The Auditory Brainstem Implant Program at the Massachusetts Eye and Ear Infirmary was founded with a generous donation from Helene and Grant Wilson.
The ABI team is comprised of pediatric and adult skull base surgeons, audiologists, neurologists, and scientists from the Massachusetts Eye and Ear Infirmary and the Massachusetts General Hospital. We provide audiologic, medical, and surgical support (including hearing aids, cochlear implants and auditory brainstem implants) for patients who have Neurofibromatosis Type 2 (NF2). Many of our patients are seen both in the NF Clinic at MGH as well as in the Departments of Otolaryngology and Audiology at MEEI.
We also care for infants, children, and adults who do not have NF2, but have deafness from conditions that do not allow for successful cochlear implant surgery. These patients may have severe congenital malformation of the inner ear (no hearing nerve or cochlea), scarring of both inner ears due to infection or meningitis, otosclerosis, injury to the hearing nerve or inner ear from a severe skull fracture, or auditory neuropathy/dyssynchrony (AN/AD).
The Massachusetts Eye and Ear Infirmary is currently conducting the only FDA approved clinical trial in the U.S. for adult deaf patients who do not have NF2 to receive the ABI.
Daniel J. Lee, M.D., F.A.C.S.
Director, Pediatric Ear, Hearing, and Balance Center, Massachusetts Eye and Ear Infirmary
Director, Wilson Auditory Brainstem Implant Program
Phone: (617) 573-3130
Department of Otology and Laryngology
Harvard Medical School
Massachusetts Eye and Ear Infirmary
243 Charles Street, Boston MA 02114-3096